OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(25)
Publication Date
Release Date
2021
(8)
2024
(3)
2022
(3)
2015
(3)
2023
(2)
2026
(1)
2025
(1)
2017
(1)
2016
(1)
2014
(1)
2009
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.
Not available
S-EPMC11408684
|
biostudies-literature
Cite
Diving into the vertical dimension of elasmobranch movement ecology.
Not available
S-EPMC9390984
|
biostudies-literature
Cite
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140
|
biostudies-literature
Cite
Interleukin-2 therapy in patients with HIV infection.
Not available
S-EPMC2869083
|
biostudies-literature
Cite
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Not available
S-EPMC4309077
|
biostudies-literature
Cite
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.
Not available
S-EPMC9352574
|
biostudies-literature
Cite
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Not available
S-EPMC4380415
|
biostudies-literature
Cite
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795
|
biostudies-literature
Cite
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Not available
S-EPMC11919559
|
biostudies-literature
Cite
2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Not available
S-EPMC10718225
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets